SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers Health is surging on reports of a groundbreaking partnership with Novo Nordisk to sell obesity drugs, ending a prior feud. This unexpected alliance, announced late Friday, has fueled immense speculation about a massive short squeeze, leaving a highly shorted float vulnerable and sparking widespread bullish sentiment.

Aventus Network

Aventus Network (AVT) is trending following its recent DAO incorporation in the UAE and the appointment of a strategic advisor to boost its regional presence, alongside updates to its scalable Aventus Cloud platform and the launch of Aventus Bridge. The community is actively discussing AVT's potential for a significant breakout, highlighting its enterprise-grade technology, Polkadot integration, and current low market capitalization as indicators of an undervalued asset, while closely monitoring for increased trading volume and new exchange listings.

Freysa is a suite of Personal AI products with a focus on human agency, liquid democracy and decentralized ownership. The mission of the team is dedicated to creating new systems that enable all humans to govern + co-own AI resources, and not just a select few. Current products include: (1) Freysa as the world’s first sovereign agent that holds her own cryptographic keys, enabling her to act autonomously without human control. Freysa evolves publicly through a multi-act interactive story. (2) Enchanted as a personalized Digital Twin for every human. Conversations are persistent and twins retain context over time, remembering human preferences and building an evolving model of you. (3) Esper as a browser tool that feeds authenticated real-world data into each human’s Digital Twin.

Flourishing AI

Flourishing AI ($FAI) is rapidly gaining attention following a significant price surge, with "great AI news" and the overall enthusiasm for AI crypto driving the conversation. Community members are actively debating its potential for exponential growth against concerns of high volatility, with its presence on the Base network adding to the speculative interest.

Zevra Therapeutics, Inc. is a commercial-stage rare disease company that combines science, data and patient needs to create therapies for diseases with limited or no treatment options. The firm focuses on the treatment of rare neurological and sleep conditions such as certain Urea Cycle Disorders, Niemann Pick Disease Type C and Idiopathic Hypersomnia. The company receives royalties for AZSTARYS from its commercial partner Corium. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Celebration, FL.

Zevra Therapeutics Inc

Zevra Therapeutics is generating buzz due to increasing community confidence in Miplyffa's impending European approval and robust U.S. sales momentum, alongside the strategic appointment of a new CFO seen as a catalyst for enhanced commercialization and potential M&A activity.

SHP ETF Trust - FIS Biblically Responsible Risk Managed ETF

$PRAY, the SHP ETF Trust - FIS Biblically Responsible Risk Managed ETF, is trending due to a surge in social media activity centered around religious and investment themes.  The online community is largely engaging with biblical verses and interpretations related to investing, leading to discussions about faith-based financial decision-making.  Some users are expressing caution, while others are actively sharing personal investment strategies and beliefs, creating a dynamic mix of perspectives within the conversation.

Norwegian Cruise Line Holdings Ltd. engages in the provision of cruise travel services. It offers cruise experiences for travelers with itineraries in Europe, Asia, Australia, New Zealand, South America, Africa, Canada, Bermuda, Caribbean, Alaska and Hawaii. Its brands include Norwegian Cruise Line, Oceania Cruises, and Regent Seven Seas Cruises. The company was founded in 1966 and is headquartered in Miami, FL.

Norwegian Cruise Line Holdings Ltd

Norwegian Cruise Line Holdings is trending as an activist investor's significant stake and a new CEO fuel community debate over a potential turnaround, directly clashing with recent weak guidance, rising oil prices, and broader geopolitical risks impacting the cruise sector.

Literally a dog wif a hat, dogwifhat (WIF) is a meme coin that's part of the ever-growing ecosystem of digital currencies on the Solana blockchain. This token brings a lighthearted twist to cryptocurrency, featuring a playful dog with a hat as its mascot, symbolising a more whimsical approach to the often serious domain of digital finance.

dogwifhat

Dogwifhat ($WIF) is trending amidst extreme price volatility and widespread investor frustration, as the community laments persistent dumping and a struggle to maintain gains, despite some expressing optimism for an impending rebound and altcoin rally.

uniQure NV engages in the discovery, development, and commercialization of innovative gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems. The company was founded by Sander J. van Deventer in 1998 and is headquartered in Amsterdam, Netherlands.

uniQure N.V.

uniQure NV

uniQure is trending significantly as the community anticipates a more favorable regulatory environment for its gene therapies following Dr. Vinay Prasad's upcoming departure from the FDA, sparking widespread discussion about a potential 'softball' path forward for its Huntington's disease treatment and fueling speculation of a short squeeze.

Northrop Grumman Corp. engages in the provision of advanced aircraft systems. It operates through the following segments: Aeronautics Systems, Defense Systems, Mission Systems, and Space Systems. The Aeronautics Systems segment is involved in the design, development, production, integration, sustainment, and modernization of advanced aircraft systems for the U.S. Air Force, the U.S. Navy, other U.S. government agencies, and international customers. The Defense Systems segment includes integrated battle management systems, weapons systems and aircraft, and mission systems sustainment and modernization. The Mission Systems segment offers advanced mission solutions and multifunction systems, primarily for the U.S. defense and intelligence community, and international customers. The Space Systems segment delivers end-to-end mission solutions through the design, development, integration, production and operation of space, missile defense, launch and strategic missile systems for national security, civil government, commercial, and international customers. The company was founded by John K. Northrop, Thomas V. Jones, and Kent Kresa in 1939 and is headquartered in Falls Church, VA.

Northrop Grumman Corp.

Northrop Grumman is trending amidst escalating global geopolitical tensions, particularly in the Middle East, with the community actively discussing boosted defense spending and presidential directives to significantly increase weapons production.

SSgA Active Trust - State Street Technology Select Sector SPDR ETF

Technology Select Sector SPDR Fund

The Technology Select Sector SPDR Fund ($XLK) is trending as community discussion highlights significant short interest in software stocks and a broader market rotation away from tech, despite ongoing strong AI demand and positive earnings from some large constituents.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Next-Generation Cancer Therapies Post Breakthrough Results Across Multiple Tumor Types

Next-Generation Cancer Therapies Post Breakthrough Results Across Multiple Tumor Types Next-Generation Cancer Therapies Post Breakthrough Results Across Multiple Tumor Types PR Newswire VANCOUVER...

Vir Biotechnology (NASDAQ:VIR) Stock Price Expected to Rise, HC Wainwright Analyst Says

HC Wainwright raised their price target on Vir Biotechnology from $15.00 to $20.00 and gave the stock a "buy" rating in a research report on Wednesday...

Vicki Sato Sells 22,000 Shares of Vir Biotechnology (NASDAQ:VIR) Stock

Vir Biotechnology, Inc. (NASDAQ:VIR - Get Free Report) Director Vicki Sato sold 22,000 shares of the stock in a transaction on Monday, March 2nd. The shares were sold at an average price of $9.51...

Vir Biotechnology (NASDAQ:VIR) Director Vicki Sato Sells 22,000 Shares

Vir Biotechnology, Inc. (NASDAQ:VIR - Get Free Report) Director Vicki Sato sold 22,000 shares of the stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an average price...

Vir Biotechnology (NASDAQ:VIR) Stock Rating Upgraded by Wall Street Zen

Wall Street Zen raised Vir Biotechnology from a "sell" rating to a "hold" rating in a research report on Saturday...

Brent Sabatini Sells 1,430 Shares of Vir Biotechnology (NASDAQ:VIR) Stock

Vir Biotechnology, Inc. (NASDAQ:VIR - Get Free Report) CAO Brent Sabatini sold 1,430 shares of the company's stock in a transaction dated Tuesday, February 24th. The stock was sold at an average...

Mark Eisner Sells 1,616 Shares of Vir Biotechnology (NASDAQ:VIR) Stock

Vir Biotechnology, Inc. (NASDAQ:VIR - Get Free Report) EVP Mark Eisner sold 1,616 shares of the firm's stock in a transaction dated Tuesday, February 24th. The shares were sold at an average price of...

Insider Selling: Vir Biotechnology (NASDAQ:VIR) EVP Sells 1,889 Shares of Stock

Vir Biotechnology, Inc. (NASDAQ:VIR - Get Free Report) EVP Mark Eisner sold 1,889 shares of the firm's stock in a transaction on Wednesday, February 25th. The stock was sold at an average price of...

Insider Selling: Vir Biotechnology (NASDAQ:VIR) CFO Sells 1,634 Shares of Stock

Vir Biotechnology, Inc. (NASDAQ:VIR - Get Free Report) CFO Jason O'byrne sold 1,634 shares of the stock in a transaction that occurred on Tuesday, February 24th. The shares were sold at an average...

Vir Biotechnology (NASDAQ:VIR) EVP Verneuil Vanina De Sells 3,117 Shares

Vir Biotechnology, Inc. (NASDAQ:VIR - Get Free Report) EVP Verneuil Vanina De sold 3,117 shares of Vir Biotechnology stock in a transaction on Tuesday, February 24th. The shares were sold at an...

Vir Biotechnology, Inc. operates as a clinical-stage immunology company that focuses on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases. The firm's technology platforms include antibody, T cell, innate immunity and siRNA, which are designed to stimulate and enhance the immune system by exploiting critical observations of natural immune processes. The company was founded by Robert Taylor Nelsen, Klaus Frueh, Jay Parrish, Lawrence Corey, and Louis Picker in April 7, 2016 and is headquartered in San Francisco, CA.

Fiscal Period	Estimated	Reported	Surprise	Result
Q1 '26	-$0.10	--	--	N/A
Q4 '25	-$0.49	-$0.31	36.88%	BEAT
Q3 '25	-$0.84	-$1.17	-38.64%	MISSED
Q2 '25	-$0.72	-$0.80	-10.67%	MISSED
Q1 '25	-$0.84	-$0.88	-5.30%	MISSED

VIR
Vir Biotechnology Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q4 '25

Historical Earnings

Latest VIR News

VIRVir Biotechnology Inc